Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trans Fat Labeling Should Help Product Comparisons, FDAer Claims

This article was originally published in The Tan Sheet

Executive Summary

FDA will conduct an "educational campaign" over the next couple of years to teach consumers about trans fat and what to consider when buying products that contain the substance, according to San Francisco District Office Public Affairs Specialist Janet McDonald, PhD
Advertisement

Related Content

CFSAN’s Levitt Unexpectedly Retires; Brackett To Take Over
CFSAN’s Levitt Unexpectedly Retires; Brackett To Take Over
CFSAN’s Levitt Unexpectedly Retires; Brackett To Take Over
Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Qualified Health Claims Scientific Evidence To Be Assessed, Ranked By FDA
Dietary Supplement “Flexible” Testing Requirements Proposed In GMPs
CFSAN Adverse Event Strategy: Will Notifying Industry Create A 2-Way Road?

Topics

Advertisement
UsernamePublicRestriction

Register

PS095779

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel